aan het Rot, M, Mathew, SJ, Charney, DS (2009). Neurobiological mechanisms in major depressive disorder. Canadian Medical Association Journal 180, 305–313.
ACS (2009). 2005–2007 American Community Survey 3-Year Estimates. U.S. Census Bureau: Washington, DC.
Anderson, IM, Parry-Billings, M, Newsholme, EA, Poortmans, JR, Cowen, PJ (1990). Decreased plasma tryptophan concentration in major depression: relationship to melancholia and weight loss. Journal of Affective Disorders 20, 185–191.
Andrews, G, Peters, L (1998). The psychometric properties of the Composite International Diagnostic Interview. Social Psychiatry and Psychiatric Epidemiology 33, 80–88.
Babcock, TA, Carlin, JM (2000). Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. Cytokine 12, 588–594.
Backdahl, L, Bushell, A, Beck, S (2009). Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. International Journal of Biochemistry and Cell Biology 41, 176–184.
Bjornsson, HT, Sigurdsson, MI, Fallin, MD, Irizarry, RA, Aspelund, T, Cui, H, Yu, W, Rongione, MA, Ekstrom, TJ, Harris, TB, Launer, LJ, Eiriksdottir, G, Leppert, MF, Sapienza, C, Gudnason, V, Feinberg, AP (2008). Intra-individual change over time in DNA methylation with familial clustering. Journal of the American Medical Association 299, 2877–2883.
Brunner, AL, Johnson, DS, Kim, SW, Valouev, A, Reddy, TE, Neff, NF, Anton, E, Medina, C, Nguyen, L, Chiao, E, Oyolu, CB, Schroth, GP, Absher, DM, Baker, JC, Myers, RM (2009). Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Research 19, 1044–1056.
Dantzer, R, O'Connor, JC, Freund, GG, Johnson, RW, Kelley, KW (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 9, 46–56.
Eckhardt, F, Lewin, J, Cortese, R, Rakyan, VK, Attwood, J, Burger, M, Burton, J, Cox, TV, Davies, R, Down, TA, Haefliger, C, Horton, R, Howe, K, Jackson, DK, Kunde, J, Koenig, C, Liddle, J, Niblett, D, Otto, T, Pettett, R, Seemann, S, Thompson, C, West, T, Rogers, J, Olek, A, Berlin, K, Beck, S (2006). DNA methylation profiling of human chromosomes 6, 20 and 22. Nature Genetics 38, 1378–1385.
Egger, G, Liang, G, Aparicio, A, Jones, PA (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457–463.
Elenkov, IJ (2008). Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochemistry International 52, 40–51.
Galecki, P, Kedziora, J, Florkowski, A, Galecka, E (2007). Lipid peroxidation and copper-zinc superoxide dismutase activity in patients treated with fluoxetine during the first episode of depression [in Polish]. Psychiatria Polska 41, 615–624.
Gimeno, D, Kivimaki, M, Brunner, EJ, Elovainio, M, De Vogli, R, Steptoe, A, Kumari, M, Lowe, GD, Rumley, A, Marmot, MG, Ferrie, JE (2009). Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychological Medicine 39, 413–423.
Gladkevich, A, Kauffman, HF, Korf, J (2004). Lymphocytes as a neural probe: potential for studying psychiatric disorders. Progress in Neuropsychopharmacology and Biological Psychiatry 28, 559–576.
Gold, SM, Irwin, MR (2009). Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Immunology and Allergy Clinics of North America 29, 309–320.
Howren, MB, Lamkin, DM, Suls, J (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71, 171–186.
Hu, B, Hissong, BD, Carlin, JM (1995). Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes. Journal of Interferon and Cytokine Research 15, 617–624.
Huang, DW, Sherman, BT, Lempicki, RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 4, 44–57.
Irwin, MR, Miller, AH (2007). Depressive disorders and immunity: 20 years of progress and discovery. Brain Behavior and Immunity 21, 374–383.
Kalman, J, Palotas, A, Juhasz, A, Rimanoczy, A, Hugyecz, M, Kovacs, Z, Galsi, G, Szabo, Z, Pakaski, M, Feher, LZ, Janka, Z, Puskas, LG (2005). Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression – evolution of antidepressants and the role of the ‘neuro-immune’ system. Neurochemical Research 30, 1429–1438.
Kang, HJ, Adams, DH, Simen, A, Simen, BB, Rajkowska, G, Stockmeier, CA, Overholser, JC, Meltzer, HY, Jurjus, GJ, Konick, LC, Newton, SS, Duman, RS (2007). Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. Journal of Neuroscience 27, 13329–13340.
Kiecolt-Glaser, JK, Glaser, R (2002). Depression and immune function: central pathways to morbidity and mortality. Journal of Psychosomatic Research 53, 873–876.
Kim, JK, Samaranayake, M, Pradhan, S (2009). Epigenetic mechanisms in mammals. Cellular and Molecular Life Sciences 66, 596–612.
Kinnally, EL, Capitanio, JP, Leibel, R, Deng, L, Leduc, C, Haghighi, F, Mann, JJ (2010). Epigenetic regulation of serotonin transporter expression and behavior in infant rhesus macaques. Genes, Brain and Behavior 6, 575–582.
Kroenke, K, Spitzer, RL, Williams, JB (2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine 16, 606–613.
Kronfol, Z, Remick, DG (2000). Cytokines and the brain: implications for clinical psychiatry. American Journal of Psychiatry 157, 683–694.
Lee, JS, Lo, PK, Fackler, MJ, Argani, P, Zhang, Z, Garrett-Meyer, E, Sukumar, S (2007). A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women. Cancer Biology and Therapy 6, 1114–1120.
Le-Niculescu, H, Kurian, SM, Yehyawi, N, Dike, C, Patel, SD, Edenberg, HJ, Tsuang, MT, Salomon, DR, Nurnberger, JI Jr., Niculescu, AB (2009). Identifying blood biomarkers for mood disorders using convergent functional genomics. Molecular Psychiatry 14, 156–174.
Leonard, BE, Myint, A (2009). The psychoneuroimmunology of depression. Human Psychopharmacology 24, 165–175.
Maes, M (1999). Major depression and activation of the inflammatory response system. Advances in Experimental Medicine and Biology 461, 25–46.
Maes, M (2008). The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuroendocrinology Letters 29, 287–291.
Maes, M, Bosmans, E, Meltzer, HY, Scharpe, S, Suy, E (1993 a). Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? American Journal of Psychiatry 150, 1189–1193.
Maes, M, Meltzer, HY, Bosmans, E, Bergmans, R, Vandoolaeghe, E, Ranjan, R, Desnyder, R (1995). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorders 34, 301–309.
Maes, M, Meltzer, HY, Scharpe, S, Bosmans, E, Suy, E, De Meester, I, Calabrese, J, Cosyns, P (1993 b). Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Research 49, 151–165.
Maes, M, Scharpe, S, Meltzer, HY, Bosmans, E, Suy, E, Calabrese, J, Cosyns, P (1993 c). Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Research 49, 11–27.
Maes, M, Verkerk, R, Vandoolaeghe, E, Van Hunsel, F, Neels, H, Wauters, A, Demedts, P, Scharpe, S (1997). Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response. European Archives of Psychiatry and Clinical Neuroscience 247, 154–161.
Maes, M, Yirmyia, R, Noraberg, J, Brene, S, Hibbeln, J, Perini, G, Kubera, M, Bob, P, Lerer, B, Maj, M (2009). The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic Brain Disease 24, 27–53.
Manji, HK, Moore, GJ, Chen, G (2000 a). Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biological Psychiatry 48, 740–754.
Manji, HK, Moore, GJ, Rajkowska, G, Chen, G (2000 b). Neuroplasticity and cellular resilience in mood disorders. Molecular Psychiatry 5, 578–593.
Mill, J, Tang, T, Kaminsky, Z, Khare, T, Yazdanpanah, S, Bouchard, L, Jia, P, Assadzadeh, A, Flanagan, J, Schumacher, A, Wang, SC, Petronis, A (2008). Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. American Journal of Human Genetics 82, 696–711.
Miller, AH, Maletic, V, Raison, CL (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 65, 732–741.
Myint, AM, Kim, YK (2003). Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Medical Hypotheses 61, 519–525.
Oberlander, TF, Weinberg, J, Papsdorf, M, Grunau, R, Misri, S, Devlin, AM (2008). Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 3, 97–106.
Olsson, CA, Foley, DL, Parkinson-Bates, M, Byrnes, G, McKenzie, M, Patton, GC, Morley, R, Anney, RJ, Craig, JM, Saffery, R (2010). Prospects for epigenetic research within cohort studies of psychological disorder: a pilot investigation of a peripheral cell marker of epigenetic risk for depression. Biological Psychology 83, 159–165.
Pepys, MB, Hirschfield, GM (2003). C-reactive protein: a critical update. Journal of Clinical Investigation 111, 1805–1812.
Petronis, A (2010). Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 465, 721–727.
Philibert, RA, Sandhu, H, Hollenbeck, N, Gunter, T, Adams, W, Madan, A (2008). The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 147B, 543–549.
Pike, BL, Greiner, TC, Wang, X, Weisenburger, DD, Hsu, YH, Renaud, G, Wolfsberg, TG, Kim, M, Weisenberger, DJ, Siegmund, KD, Ye, W, Groshen, S, Mehrian-Shai, R, Delabie, J, Chan, WC, Laird, PW, Hacia, JG (2008). DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia 22, 1035–1043.
Ptak, C, Petronis, A (2010). Epigenetic approaches to psychiatric disorders. Dialogues in Clinical Neuroscience 12, 25–35.
Ranjit, N, Diez-Roux, AV, Shea, S, Cushman, M, Seeman, T, Jackson, SA, Ni, H (2007). Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Archives of Internal Medicine 167, 174–181.
Schiepers, OJ, Wichers, MC, Maes, M (2005). Cytokines and major depression. Progress in Neuropsychopharmacology and Biological Psychiatry 29, 201–217.
Sluzewska, A, Rybakowski, J, Bosmans, E, Sobieska, M, Berghmans, R, Maes, M, Wiktorowicz, K (1996). Indicators of immune activation in major depression. Psychiatry Research 64, 161–167.
Stenvinkel, P, Karimi, M, Johansson, S, Axelsson, J, Suliman, M, Lindholm, B, Heimburger, O, Barany, P, Alvestrand, A, Nordfors, L, Qureshi, AR, Ekstrom, TJ, Schalling, M (2007). Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease? Journal of Internal Medicine 261, 488–499.
Trzonkowski, P, Mysliwska, J, Godlewska, B, Szmit, E, Lukaszuk, K, Wieckiewicz, J, Brydak, L, Machala, M, Landowski, J, Mysliwski, A (2004). Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain, Behavior, and Immunity 18, 135–148.
Uddin, M, Aiello, AE, Wildman, DE, Koenen, KC, Pawelec, G, de Los Santos, R, Goldmann, E, Galea, S (2010). Epigenetic and immune function profiles associated with posttraumatic stress disorder. Proceedings of the National Academy of Sciences USA 107, 9470–9475.
Valinluck, V, Sowers, LC (2007). Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Research 67, 946–950.
Weaver, IC, Cervoni, N, Champagne, FA, D'Alessio, AC, Sharma, S, Seckl, JR, Dymov, S, Szyf, M, Meaney, MJ (2004). Epigenetic programming by maternal behavior. Nature Neuroscience 7, 847–854.
Weaver, IC, Champagne, FA, Brown, SE, Dymov, S, Sharma, S, Meaney, MJ, Szyf, M (2005). Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. Journal of Neuroscience 25, 11045–11054.
Wrona, D (2006). Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. Journal of Neuroimmunology 172, 38–58.